Mycobacterium avium complex infections: A review of treatments;Infections a mycobacteries du complexe aviaire: Le point sur les traitements

Therapie

Volumn 52, Issue 1, 1997, Pages 65-71

  Brandissou, S ^a   Hamel, B ^a   Veillet, B ^a   Kinowski, J M ^a   Yagoubi, N ^a   Bressolle, F ^a  

^a DEPARTMENT OF NEUROLOGY   (France)

Author keywords

AIDS; azithromycin; clarithromycin; clofazim ine; ethambutol; mycobacterium avium complex; rifabutin

Indexed keywords

AMIKACIN; AZITHROMYCIN; CIPROFLOXACIN; CLOFAZIMINE; ETHAMBUTOL; GENTAMICIN; RIFABUTIN; RIFAMPICIN; ANTIINFECTIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; AIDS RELATED COMPLEX; ATYPICAL MYCOBACTERIOSIS; DRUG COMBINATION; MYCOBACTERIUM INTRACELLULARE AVIUM;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HUMANS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION;

EID: 0030632510     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Horsburgh CR, Selik RM. The epidemiology of non tuberculous mycobacterial infection in the Acquired Immunodeficiency Syndrome (AIDS). Am Rev Respir Dis 1989; 139: 4-7.
2. Nightingale SD, Byrd LT, Southern PM et al. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992; 165: 1082-1085.
3. Benson CA, Ellner JJ. Mycobacterium avium complex infection and AIDS:advances in theory and practice. Clin Infect Dis 1993; 17: 7-20.
4. Horsburgh CR. Mycobacterium avium complex infection in the Acquired Immunodeficiency Syndrome. N Engl J Med 1991; 324: 1332-1338.
5. Pellegrin JL, Lasseur C. Les infections à mycobactéries atypiques au cours de l'infection à VIH: épidémiologie et incidence. La Lettre de l'Infectiologue; Décembre 1993: no hors série.
6. Horsburgh CR Jr, Chin DP, Yajko DM et al. Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infection. J Infect Dis 1994; 170: 362-367.
7. Jacobson MA, Hopewell PC, Yajko DM et al. Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 1991; 164: 994-998.
8. Horsburgh CR Jr, Metchock BG, Mc Gowan JE Jr, Thompson SE. Clinical implications of recovery of Mycobacterium avium complex from the stool or respiratory tract of HIV-infected individuals (letter) AIDS 1992; 6: 512-514.
9. Havlik JA, Horsburgh CR, Metchock BG et al. Disseminated Mycobacterium avium complex infection: clinical identification. J Infect Dis 1992; 165: 577-580.
10. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T, the Zidovudine Epidemiology Study Group. Incidence and natural history of Mycobacterium avium complex infections in patients with human immunodeficiency virus disease treated with zidovudine. Am Rev Respir Dis 1992; 146: 285-289.
11. Sathes S, Gascon P, Lo W et al. Severe anemia is an important negative predictor for survival with disseminated Mycobacterium avium-intracellulare in acquired immunodeficiency syndrome. Am Rev Respir Dis 1990; 142: 1306-1312.
12. Crowe SM, Carlin JB, Stewart KI et al. Predictive value of CD4 lymphocyte number for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991; 4: 770-776.
13. Farhi DC, Mason UG III, Horsburgh CR. Pathologic findings in disseminated Mycobacterium avium-intracellulare infection. Am J Clin Pathol 1986; 85: 67-72.
14. Welch K, Finkreiner W, Alpers CF et al. Autopsy Findings in the acquired immunodeficiency syndrome. JAMA 1984; 1152-1159.
15. Torriani FJ, Mc Cutchan A, Bozzette SA et al. Autopsy findings in AIDS patients with Mycobacterium avium complex bacteremia. J Infect Dis 1994; 170: 1601-1605.
16. Benson CA. Disease due to the Mycobacterium avium complex in patients with AIDS: Epidemiology and clinical syndrome. Clin Inf Dis 1994; 18(suppl 3): S218-S222.
17. Horsburgh CR Jr, Metchock BG, Gordon SM et al. Predictors of survival in patients with AIDS and disseminated Mycobacterium avium complex disease. J Inf Dis 1994; 170: 573-577.
18. Chin DP, Reingol AL, Stone EN et al. The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients - A prospective study. J Inf Dis 1994; 170: 578-584.
19. Dautzenberg B, Truffot C, Legris S et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome: a controlled clinical trial. Am Rev Respir Dis 1991; 144: 564-569.
20. Chaisson RE, Benson C, Dube M et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomised, double-blind, dose-ranging study in patients with AIDS. Ann Inter Med 1994; 121(12): 905-911.
21. Gupta S, Blahunka K, Dellerson M et al. Interim results of safety and efficacy of clarithromycin (C) in the treatment of disseminated Mycobacterium avium complex (MAC) infection in patients (Pts) with AIDS (Abstract no 892). In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1992.
22. Young LS, Wiviott L, Wu M et al. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 1991; 338: 1107-1109.
23. Cynamon MH, Klemens SP, Grossi MA. Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. Antimicrob Agents Chemother 1994; 38(7): 1452-1454.
24. Dautzenberg B, Truffot C, Legrand MF et al. Relapses of M avium infection in 23 HIV-positive and 8 HIV-negative patients receiving clarithromycin. Program and abstracts. Frontiers in mycobacteriology: M. avium, the modern epidemic, abstr. 53, Vail, Colorado, 1992
25. Heifets L, Mor N, Vanderkolk J. Mycobacterium avium strains resistant to clarithromycin and azithromycin. Antimicrob Agents Chemother 1993; 37(11): 2364-2370.
26. Heifets L, Iseman MD. Determination of in vitro susceptibility of mycobacteria to ansamycin. Am Rev Respir Dis 1985; 132: 710-711.
27. Kallenius G, Svenson SG, Hoffner SE. Ethambutol: a key for Mycobacterium avium complex chemotherapy. Am Rev Respir Dis 1989; 140: 264.
28. Nightingale SD, Saletan SL, Swenson CE et al. Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients. Antimicrob Agents Chemother 1993; 37(9): 1869-1872.
29. Kemper CA, Havlir D, Haghighat D et al. The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin on Mycobacterium avium complex bacteremia in patients with AIDS. J Infect Dis 1994; 170: 157-164
30. Benson CA. Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS. Clin Infect Dis 1994; 18(suppl 3): S237-S242.
31. Vittecoq D. Ansatipine: pourquoi une autorisation d'AMM pour le traitement préventif et non pour le traitement curatif des mycobactérioses aviaires au cours du SIDA? La Lettre de l'Infectiologue Décembre 1993; numéro hors-série: 26-27.
32. Klemens SP, Grossi MA, Cynamon MH. Comparative in vivo activities of rifabutine and rifapentine against Mycobacterium avium complex. Antimicrob Agents Chemother 1994; 38 (2): 234-237.
33. Shafran SD, Deschenes J, Miller M et al. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin and ethambutol. Correspondence. N Engl J Med 1994, 330: 438-439.
34. Seydel JK, Schaper K-J, Rusch-Gerdes S. Development of effective drug combinations for the inhibition of multiresistant mycobacteria, especially for the Mycobacterium avium complex. Chemotherapy 1992; 38: 159-168.
35. Chiu J, Nussbaum J, Bozzette S et al. Treatment of disseminated Mycobacterium avium complex infections in AIDS with amikacine, ethambutol, rifampin and ciprofloxacin. Ann Inter Med 1990; 113: 358-361.
36. Kemper CA, Meng TC, Nussbaum J et al. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen: rifampin, ethambutol, clofazimine and ciprofloxacin. Ann Inter Med 1992; 116: 466-472.
37. Gordon SM, Horsburgh CR Jr, Peloquin CA et al. Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. J Infect Dis 1993; 168: 1559-1562.
38. Jacobson MA, Yajko D, Northfelt D et al. Randomized, placebo controlled trial of rifampin, ethambutol and ciprofloxacin for patients with disseminated Mycobacterium avium complex infection. J Infect Dis 1993; 168: 112-119.
39. Dautzenberg B, Hazebroucq J, Chauvin JP. Clarithromycin in 100 AIDS patients with disseminated Mycobacterium avium infection (abstract no 893). In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1992
40. De Lalla F, Maserati R, Scarpellini P et al. Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. Antimicrob Agents Chemother 1992; 36(7): 1567-1569.
41. St Marc T, Touraine JL. Clinical experience with a combination of clarithromycin and clofazimine in the treatment of disseminated Mycobacterium avium infections in AIDS patients (abstract no 237). In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1991
42. May Th, Vincent V, Brel F, Beuscart CL, Perronne C, Doco-Lecompte T, Dautzenberg B, Grosset J, and Curavium group. The French randomized clinical trial of combination therapy with clarithromycin for MAC bacteremia in AIDS patients: final results. (A paraître).
43. Chaisson RE, Keiser P, Pierce M et al. Controlled trial of clarithromycin/ethambutol with or without clofazimine for the treatment of Mycobacterium avium complex bacteremia in AIDS patients. Abstract. In: 3rd conference on retroviruses and opportunistic infections, Washington DC, 1996.
44. Sullam PM, Gordin FM, Wynne BA. Efficacy of rifabutin in the treatment disseminated infection due to Mycobacterium avium complex. The rifabutin treatment group. Clin Infect Dis 1994; 19(1): 84-86.
45. Dautzenberg B, Olliaro P, RUfB et al. Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS. Clin Infect Dis 1996, 22: 705-708.
46. Onyeji CO, Nightingale CH, Nicolau DP, Quintiliani R. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-Mycobacterium intracellulare complex in human macrophages. Antimicrob Agents Chemother 1994; 38(3): 523-527.
47. Jagannath C, Reddy VM, Gangadharam PRJ. Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxide. J Antimicrob Chemother 1995; 35: 381-390.